Escalon Medical Corp.

Total Valuation

Escalon Medical Corp. carries a market capitalization of 1.37M, placing it among publicly traded companies globally. Its enterprise value stands at -352,199.78, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Escalon Medical Corp. currently has 7.42M shares outstanding.

Valuation Ratios

Escalon Medical Corp. trades at a trailing price-to-earnings ratio of 1.69. The price-to-sales ratio is 0.12, and the price-to-book ratio stands at -0.02.

Enterprise Valuation

On an enterprise value basis, Escalon Medical Corp. trades at an EV/EBITDA multiple of 3.64 and an EV/FCF ratio of 5.27. The EV/Sales ratio of 0.39 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.67 provides insight into valuation relative to core operating earnings.

Financial Position

Escalon Medical Corp. maintains a current ratio of 2.59, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 24.37, indicating elevated leverage, while an interest coverage ratio of -53.30 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Stock Price Statistics

Escalon Medical Corp.'s stock has declined approximately -42.1875% over the past 52 weeks. The 50-day moving average sits at 0.19, while the 200-day moving average is 0.18.

Income Statement

Over the trailing twelve months, Escalon Medical Corp. generated 11.45M in revenue and converted that into 1.85M in net income, yielding earnings per share of 0.15. EBITDA reached -866,906.00, while operating income came in at -895,045.00.

Balance Sheet

Escalon Medical Corp. holds 3.34M in cash and equivalents against 1.01M in total debt, resulting in a net debt position of -3.20M. Total book value stands at -66.20M, with working capital of 4.03M providing operational flexibility.

Cash Flow

Escalon Medical Corp. produced -135,664.00 in operating cash flow over the past twelve months. After subtracting -8,301.00 in capital expenditures, free cash flow totaled -143,965.00 - equivalent to -0.02 per share.

Margins

Escalon Medical Corp. operates with a gross margin of 41.48, reflecting its pricing power and cost economics. The operating margin of -7.82 and net profit margin of 16.18 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of -133.89 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Escalon Medical Corp.'s most recent stock split took place on November 24, 1997 with a 4:1 split ratio.

Scores

Escalon Medical Corp. posts an Altman Z-Score of -10.31, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.